Murine coronavirus neurovirulence: role of type I interferon response

鼠冠状病毒神经毒力:I 型干扰素反应的作用

基本信息

  • 批准号:
    8419399
  • 负责人:
  • 金额:
    $ 34.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-01 至 2017-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Viral infections of the central nervous system (CNS) can cause both acute and chronic diseases that devastate the host. This proposal aims to investigate the extent and effectiveness of the host's type I interferon (IFN) response in restricting virus replication and spread in the CNS, and in addition, the mechanisms used by viruses to antagonize the IFN response. Infection of mice with the murine coronavirus, mouse hepatitis virus (MHV), offers a convenient and compelling model for studying virus-induced encephalitis and chronic demyelinating diseases such as multiple sclerosis (MS). Using a collection of viral strains and mutants that display different tropisms and virulence levels, we showed previously that the extent of MHV neurovirulence depends on a combination of viral and host factors, including the type I IFN response (primarily IFN-¿/¿), an early and crucial response to viral invasion. MHV infects several CNS cell types, including neurons and glial cells, cells types that have been reported to express interferon-stimulated genes (ISGs) during infection of the CNS with multiple viruses. However, the basal expression level of these ISGs, crucial for detection of viral invasion and antiviral response, is lower in the brain compared with other organs. Consequently, the CNS may be less prepared to quickly respond to viral invasion. Also contributing to the virus-host interactions, MHV encodes multiple type I IFN antagonists, most notably the ns2 protein that confers antagonism of the potent antiviral 2',5'-oligoadenylate synthetase-ribonuclease L (OAS-RNaseL) pathway that is induced by IFN. In addition the highly neurovirulent JHM.WU strain antagonizes IFN- ¿/¿ induction. Based on these findings, we propose to use the mildly neurovirulent A59 strain as well as JHM.WU to test the following overall hypothesis: IFN- ¿/¿ signaling in the CNS can effectively restrict neurovirulent MHV spread in vivo. At the same time MHV has the ability to compromise the type I IFN response through cell-type specific IFN antagonism. The virus-host balance will depend on the tissue and cell types infected and virus strain-specific proteins that compromise the IFN-¿/¿ response. The following aims are proposed: 1) Determine the cell types that restrict neurovirulent MHV infection in the CNS in vivo, using A59 and JHM.WU along with mice deficient in type I IFN receptor expression, specifically in macrophage/microglia, neuroectodermal cells or neurons; 2) Investigate the effectiveness of the OAS-RNaseL pathway in limiting MHV induced pathology during acute and chronic CNS infection and 3) Map the genes and investigate the mechanisms underlying type I IFN antagonism and high neurovirulence of JHM.WU. Understanding the immune mechanisms and the CNS cell types that limit viral pathogenesis and characterizing the strategies used by neurovirulent MHV to evade the host type I IFN response will likely aid in the development of better therapeutics to treat virus-induced encephalitis in humans. Moreover, understanding type I IFN signaling in the CNS may aid in developing or refining therapeutic applications for type I IFNs, which are currently used in treatment of MS and hepatitis C. PUBLIC HEALTH RELEVANCE: Infections with neurovirulent viruses can induce encephalitis and sometimes cause chronic central nervous system (CNS) disease. The proposed studies, using murine coronavirus infection of its natural host as a model system, will contribute to the understanding of the virus-host interactions that underlie virus-induced CNS disease and in the longer term contribute to the design of therapeutic strategies. These studies will, in addition, contribute to the understanding of interferon-¿/¿ signaling in the CNS and potentially to the refinement of type I interferon therapies for viral infections and multiple sclerosis.
描述(由适用提供):中枢神经系统(CNS)的病毒感染会导致急性和慢性疾病破坏宿主。该提案旨在研究宿主I型干扰素(IFN)反应在限制病毒复制和扩散中枢神经系统中的范围和有效性,此外,病毒用来拮抗IFN反应的机制。小鼠感染鼠冠状病毒,小鼠肝炎病毒(MHV),为研究病毒诱导的脑炎和慢性脱髓鞘性疾病(如多发性硬化症(MS))提供了方便而引人注目的模型。我们使用表现出不同的朝向主义和病毒水平的病毒菌株和突变体的集合,以前表明,MHV神经病毒的程度取决于病毒和宿主因子的组合,包括I型IFN反应(主要是IFN-ifn-®/¿),早期和对病毒入侵的早期和关键反应。 MHV感染了几种CNS细胞类型,包括神经元和神经胶质细胞,据报道在具有多种病毒的中枢神经系统感染期间,已据报道表达干扰刺激的基因(ISGS)。但是,与其他器官相比,大脑中这些ISG的基本表达水平,对于病毒侵袭和抗病毒反应至关重要。因此,中枢神经系统可能不太准备快速应对病毒侵袭。 MHV还促进了病毒宿主相互作用,编码了多种I类IFN拮抗剂,最著名的是赋予潜在抗病毒2',5'- 5'-橄榄核酸合成酶核糖核酸酶L(OAS-RNASEL)l(OAS-RNASEL)途径的NS2蛋白。另外,高度神经病毒JHM.WU菌株会拮抗Ifn-»诱导。基于这些发现,我们建议使用轻度神经病毒剂A59菌株以及JHM.WU测试以下总体假设:中枢神经系统中的IFN-€ /¿同时,MHV具有通过细胞类型特异性IFN拮抗作用损害I型IFN响应的能力。病毒宿主的平衡将取决于损害IFN-€ /€反应的感染的组织和细胞类型和病毒菌株特异性蛋白。提出了以下目的:1)使用A59和JHM.WU以及在巨噬细胞/小胶质细胞,神经外科疾病细胞或神经元中,使用A59和JHM.WU确定限制了体内中枢神经系统MHV感染的细胞类型; 2)研究OAS-RNASEL途径在限制MHV诱导的急性和慢性中枢神经系统感染过程中的有效性,3)绘制基因并研究JHM.WU的I型IFN拮抗和高神经病毒的机制。了解限制病毒发病机理的免疫力学和CNS细胞类型,并表征神经病毒MHV逃避宿主I型IFN反应的策略,可能有助于开发更好的治疗剂来治疗人类病毒诱导的脑炎。此外,了解中枢神经系统中的I型IFN信号传导可能有助于开发或完善I型IFN的治疗应用,这些应用当前用于治疗MS和丙型肝炎。 公共卫生相关性:神经病毒感染会诱导脑炎,有时会引起慢性中枢神经系统(CNS)疾病。提出的研究将其自然宿主作为模型系统的鼠冠状病毒感染,将有助于理解病毒诱导的中枢神经系统疾病的病毒宿主相互作用,从而有助于治疗策略的设计。此外,这些研究将有助于理解中枢神经系统中的干扰素信号传导,并有可能有助于对病毒感染和多发性硬化症的I型干扰素疗法的完善。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Susan R Weiss其他文献

Aggregation of Enveloped Viruses By Platelet Factor 4 (PF4) and Neutrophil Extracellular Traps (NETs): Implications for the Anti-Viral Properties of NETs
  • DOI:
    10.1182/blood-2022-170781
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Kandace Gollomp;Irina Chernysh;Anh T.P. Ngo;Nathan Levine;Sergey Zaytsev;Veronica Bochenek;Lubica Rauova;Nicholas Parenti;Susan R Weiss;John W. Weisel;Douglas B. Cines;Mortimer Poncz
  • 通讯作者:
    Mortimer Poncz

Susan R Weiss的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Susan R Weiss', 18)}}的其他基金

Three-dimensional human epithelial cultures as a model for evaluation of flavivirus-host interactions driving infection in the skin
三维人类上皮培养物作为评估驱动皮肤感染的黄病毒-宿主相互作用的模型
  • 批准号:
    10303730
  • 财政年份:
    2021
  • 资助金额:
    $ 34.51万
  • 项目类别:
Three-dimensional human epithelial cultures as a model for evaluation of flavivirus-host interactions driving infection in the skin
三维人类上皮培养物作为评估驱动皮肤感染的黄病毒-宿主相互作用的模型
  • 批准号:
    10416065
  • 财政年份:
    2021
  • 资助金额:
    $ 34.51万
  • 项目类别:
MERS coronavirus: antagonism of double-stranded RNA induced host response by accessory proteins
MERS 冠状病毒:辅助蛋白拮抗双链 RNA 诱导的宿主反应
  • 批准号:
    10265719
  • 财政年份:
    2020
  • 资助金额:
    $ 34.51万
  • 项目类别:
MERS coronavirus: antagonism of double-stranded RNA induced host response by accessory proteins
MERS 冠状病毒:辅助蛋白拮抗双链 RNA 诱导的宿主反应
  • 批准号:
    10396471
  • 财政年份:
    2018
  • 资助金额:
    $ 34.51万
  • 项目类别:
MERS coronavirus: antagonism of double-stranded RNA induced host response by accessory proteins
MERS 冠状病毒:辅助蛋白拮抗双链 RNA 诱导的宿主反应
  • 批准号:
    9915887
  • 财政年份:
    2018
  • 资助金额:
    $ 34.51万
  • 项目类别:
Betacoronaviruses: activation and antagonism of host innate immune responses
β冠状病毒:宿主先天免疫反应的激活和拮抗
  • 批准号:
    10735058
  • 财政年份:
    2018
  • 资助金额:
    $ 34.51万
  • 项目类别:
Role of type I interferon signaling in Zika virus infection of the brain
I 型干扰素信号在寨卡病毒大脑感染中的作用
  • 批准号:
    9256709
  • 财政年份:
    2016
  • 资助金额:
    $ 34.51万
  • 项目类别:
Control of coronavirus pathogenesis by antagonism of RNase L
通过拮抗 RNase L 控制冠状病毒的发病机制
  • 批准号:
    9089867
  • 财政年份:
    2015
  • 资助金额:
    $ 34.51万
  • 项目类别:
Murine coronavirus neurovirulence: role of type I interferon response
鼠冠状病毒神经毒力:I 型干扰素反应的作用
  • 批准号:
    8536418
  • 财政年份:
    2012
  • 资助金额:
    $ 34.51万
  • 项目类别:
Murine coronavirus neurovirulence: role of type I interferon response
鼠冠状病毒神经毒力:I 型干扰素反应的作用
  • 批准号:
    8847415
  • 财政年份:
    2012
  • 资助金额:
    $ 34.51万
  • 项目类别:

相似国自然基金

玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
  • 批准号:
    42307523
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
面向肝癌射频消融的智能建模与快速动力学分析方法研究及其临床验证
  • 批准号:
    62372469
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
IRF9调控CD8+T细胞介导微波消融联合TIGIT单抗协同增效抗肿瘤的作用机制
  • 批准号:
    82373219
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
建立可诱导细胞消融系统揭示成纤维细胞在墨西哥钝口螈肢体发育及再生中的作用
  • 批准号:
    32300701
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肿瘤源PPIA介导结直肠癌肝转移射频消融术残瘤化疗抵抗的机制研究
  • 批准号:
    82302332
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Redox stress resilience in aging skeletal muscle
衰老骨骼肌的氧化还原应激恢复能力
  • 批准号:
    10722970
  • 财政年份:
    2023
  • 资助金额:
    $ 34.51万
  • 项目类别:
TLR Transduction of Dysbiotic Pelvic Pain
生态失调性盆腔疼痛的 TLR 转导
  • 批准号:
    10737191
  • 财政年份:
    2023
  • 资助金额:
    $ 34.51万
  • 项目类别:
Formation of a functional tendon enthesis during development and healing
在发育和愈合过程中形成功能性肌腱附着点
  • 批准号:
    10587399
  • 财政年份:
    2023
  • 资助金额:
    $ 34.51万
  • 项目类别:
Glomerular and Tubular Function in the Recovering Kidney
肾脏恢复中的肾小球和肾小管功能
  • 批准号:
    10587898
  • 财政年份:
    2023
  • 资助金额:
    $ 34.51万
  • 项目类别:
Monocyte-Derived Microglia in Development and after Neonatal Brain Injury
发育中和新生儿脑损伤后的单核细胞衍生的小胶质细胞
  • 批准号:
    10593385
  • 财政年份:
    2023
  • 资助金额:
    $ 34.51万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了